Skip to main content

Peer Review reports

From: Efficacy and safety of minodronate in the treatment of postmenopausal osteoporosis with low back pain: a single-centre, randomized and open-label controlled trial

Original Submission
10 Dec 2022 Submitted Original manuscript
22 Feb 2023 Reviewed Reviewer Report - Muslim Syed
11 Sep 2023 Author responded Author comments - Huan Wang
Resubmission - Version 2
11 Sep 2023 Submitted Manuscript version 2
17 Sep 2023 Reviewed Reviewer Report - Muslim Syed
11 Oct 2023 Reviewed Reviewer Report - Paola Aiello
11 Oct 2023 Reviewed Reviewer Report - Onome Abiri
19 Oct 2023 Author responded Author comments - Huan Wang
Resubmission - Version 3
19 Oct 2023 Submitted Manuscript version 3
30 Oct 2023 Reviewed Reviewer Report - Onome Abiri
20 Jan 2024 Reviewed Reviewer Report - Abdulafeez Akinloye
1 Jul 2024 Author responded Author comments - Huan Wang
Resubmission - Version 4
1 Jul 2024 Submitted Manuscript version 4
20 Jul 2024 Author responded Author comments - Huan Wang
Resubmission - Version 5
20 Jul 2024 Submitted Manuscript version 5
Publishing
1 Aug 2024 Editorially accepted
13 Aug 2024 Article published 10.1186/s13063-024-08364-7

You can find further information about peer review here.

Back to article page